FDA issued a Warning Letter to Bayer Pharma AG on 11/14/2017 as a result of this inspection.
FDA investigators audited the Bayer AG - Leverkusen, Germany facility and issued 11 inspectional observations (via FDA 483) on 20 Jan 2017.
Add To Cart
- Category: Human Drugs
- Number of Observations: 11
- Inspection end: 20 Jan 2017
- Location: Leverkusen, Germany
- FEI: 3002806462